clasto-lactacystin beta-lactone has been researched along with beta-lactams in 2 studies
| Studies (clasto-lactacystin beta-lactone) | Trials (clasto-lactacystin beta-lactone) | Recent Studies (post-2010) (clasto-lactacystin beta-lactone) | Studies (beta-lactams) | Trials (beta-lactams) | Recent Studies (post-2010) (beta-lactams) |
|---|---|---|---|---|---|
| 85 | 0 | 15 | 7,579 | 179 | 3,395 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akopian, T; Craiu, A; Fenteany, G; Gaczynska, M; Goldberg, AL; Gramm, CF; Rock, KL | 1 |
| Corey, EJ; Hogan, PC | 1 |
2 other study(ies) available for clasto-lactacystin beta-lactone and beta-lactams
| Article | Year |
|---|---|
Lactacystin and clasto-lactacystin beta-lactone modify multiple proteasome beta-subunits and inhibit intracellular protein degradation and major histocompatibility complex class I antigen presentation.
Topics: Acetylcysteine; Animals; Anti-Bacterial Agents; Antigen Presentation; Base Sequence; beta-Lactams; Cell Line; Cricetinae; Cysteine Endopeptidases; Histocompatibility Antigens Class I; Humans; Lactones; Mice; Molecular Sequence Data; Multienzyme Complexes; Proteasome Endopeptidase Complex | 1997 |
Proteasome inhibition by a totally synthetic beta-lactam related to salinosporamide A and omuralide.
Topics: beta-Lactams; Drug Stability; Half-Life; Kinetics; Lactones; Proteasome Inhibitors; Pyrroles | 2005 |